The FDA has issued a proposal to remove a common decongestant in over the counter products.

Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden ...

Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps ...

One year after reports of supply chain issues, 49% of reports in the US and 34% of reports in Canada were associated with ...

The Orphan Drug designation was supported by preclinical research and preliminary data from the dose escalation/expansion phase 1/2 trial.

HealthDay News — The prevalence of diabetes was 15.8% among US adults during August 2021 to August 2023, according to a November data brief published by the National Center for Health Statistics.

Credit: Journey Medical Corporation. The approval was supported by data from 2 randomized, double-blind, active- and ...

Medication abortion before confirmed intrauterine pregnancy is noninferior to standard, delayed treatment for complete abortion.

Policies varied in the testing required, funding, processes after a positive screening result, and decision-making around concerning results. HealthDay News — Institutional leaders consider policies ...

Clear cell hidradenoma is a tumor that results from overgrowth of either eccrine or apocrine sweat glands. Lesions are most ...

The PDUFA target date is August 21, 2025. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for donidalorsen for the prophylactic treatment of hereditary ...

GLP-1 receptor agonist use in the perioperative period should be based on shared decision-making of patient and care teams.